Verastem, Inc. (VSTM)
5.68
-0.14
(-2.41%)
USD |
NASDAQ |
Mar 03, 16:00
5.685
0.00 (0.00%)
After-Hours: 20:00
Verastem Research and Development Expense (Annual) : 81.33M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 6.974B |
| ADMA Biologics, Inc. | 4.762M |
| Zevra Therapeutics, Inc. | 35.71M |
| Immuneering Corp. | 47.72M |
| Tango Therapeutics, Inc. | 143.92M |